Skip to content

CNO Financial Group Inc

US · CNO #2134 by market cap Listed 1970
52.99 -1.05 -1.94%
Live - 5344 symbols - heartbeat 508s ago · 2026-10-07 19:54
After-hours 52.99 0.00%
Market cap
4.90B
P/B
1.89
EPS
2.30
Reader sentiment Are you bullish or bearish on CNO?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Near fair value
3.44 fair value ≈ 35.92 68.41
  • Implied fair-value range of 3.44-68.41, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +47.5% above the average-multiple fair value of 35.92.

Valuation each multiple against its own 5-year range

P/B ratio 1.93 Expensive vs history 89th percentile
5-year average 1.37 · #18 of 22 in Insurance - Life
P/E ratio 18.69 Expensive vs history 81st percentile
5-year average 15.62 · forward 11.77 · #14 of 18 in Insurance - Life
P/S ratio 1.08 Expensive vs history 96th percentile
5-year average 0.79 · forward 1.24 · #15 of 22 in Insurance - Life

Vs. peers Insurance - Life

Company Market cap P/E (TTM) P/B Div yield
CNO Financial Group Inc (CNO) 4.90B 18.27 1.89 1.30%
Manulife Financial (MFC) 68.93B 16.10 2.11 3.13%
MetLife (MET) 60.87B 18.35 2.22 2.40%
Aflac Inc (AFL) 56.52B 12.16 1.86 2.11%
Prudential Financial (PRU) 38.76B 10.19 1.23 4.89%
Prudential (PUK) 29.39B 8.28 1.48 2.26%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value54.53 Economic moatNone UncertaintyHigh

Trading 2.9% below Morningstar's fair value estimate.

Fair value

CNO Financial Group Inc earns a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a price consistent with our quantitative fair value estimate, which has a high uncertainty rating.

The company's valuation metrics increase our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its enterprise value to market value ratio of 1.7, which lies in the top 20% compared with peers globally. While highly leveraged firms can be risky, they can also be highly rewarding. This company's high enterprise value relative to its market value suggests that wise investments will yield outsize returns for investors. This benefit contributes to our balanced fair value estimate.

The firm's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 4.2, for example, ranks in the bottom 30% compared with peers globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our neutral price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is fairly-valued, this outperformance had a negative impact on our valuation estimate.

Economic moat

The company's quantitative economic moat rating of none suggests any excess returns could erode quickly as competition arrives. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.